Xilong Scientific (002584) Fundamentals 2026 — Revenue Analysis | SniperIQ
Xilong Scientific (002584) is a CN-listed Basic Materials company in Chemicals with a market capitalization of ¥4.1B, trading at ¥6.98 on the SHZ. This SniperIQ fundamentals page covers Xilong Scientific's valuation, profitability (net margin -1.0%), revenue (¥7.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Xilong Scientific's market cap?
Xilong Scientific (002584) has a market capitalization of approximately ¥4.1B, trading at ¥6.98 on the SHZ. Market cap moves with the live share price.
What is Xilong Scientific's P/E ratio?
Xilong Scientific's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Xilong Scientific?
Xilong Scientific runs a net profit margin of -1.0%, a gross margin of 7.4%, and an operating margin of 1.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Xilong Scientific generate?
Xilong Scientific reported revenue of ¥7.3B for fiscal year 2025, with net income of -¥75M and earnings per share (EPS) of -0.13. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Xilong Scientific pay a dividend?
Xilong Scientific does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Xilong Scientific financially healthy?
Xilong Scientific carries a debt-to-equity ratio of 0.54x and a current ratio of 1.50x, with a market beta of 0.54. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Xilong Scientific a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Xilong Scientific (002584) the key facts are: market cap ¥4.1B, revenue ¥7.3B, 52-week range 6.23-11.75. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Xilong Scientific's full fundamentals live
Get Xilong Scientific's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.